Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds

. July 12, 2024 8:00 AM EDT | Source: Phio Pharmaceuticals Corp. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. In consideration for the immediate exercise of the warrants for cash and the payment of additional $0.125 per new unregistered warrant (additional$136,321.50 in the aggregate, which are included in the gross proceeds to the Company), the exercising holders will receive new unregistered warrants to purchase shares of common stock in a private placement pursuant ...